Loading stock data…
PMGC Holdings Inc. (ELAB)
$4.85-0.36 (-6.91%)
Market ClosedLast close Sep 8
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
PMGC Holdings Inc. in the Healthcare sector is trading at $4.85 with a market capitalization of $8M. The stock is currently near its 52-week low of $4.82, remaining 97.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 24 is oversold, raising the odds of a near-term bounce. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 24) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $681,994↑ | $304,136↑ | $285,948 | $0 | $0 |
| Gross Profit | $230,474↑ | $107,284↑ | $78,030 | — | $0 |
| Operating Income | -$3.32M↓ | -$2.41M↓ | -$2.19M↓ | -$1.01M↑ | -$1.20M |
| Net Income | -$4.97M↓ | -$2.98M↓ | -$2.59M↓ | -$562,355↑ | -$1.61M |
Peer Comparison
JNJUNHPFE
Fundamentals
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precisio...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.22M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.28
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-88.10%
Volume
Today's trading volume
29,978
Recent News
PMGC Holdings Signs Orbit2Orbit Term Sheet for Microgravity Muscle Research
PMGC Holdings Inc. (NASDAQ:ELAB) has entered into a non-binding term sheet with Australian space technology company Orbit2Orbit Pty Ltd, setting out a potential collaboration spanning space-based biomedical research, aerospace manufacturing and a strategic equity investment.
PMGC Holdings Advances EL-22 FACS Analysis to Support Manufacturing Comparability
The planned analytical study is designed to strengthen manufacturing characterization of EL-22 as development of the company’s engineered probiotic therapy continues. Key Investor TakeawaysPMGC Holdings (NASDAQ:ELAB), through subsidiary NorthStrive Biosciences, plans to begin an independent EL-22 FACS analysis program.
PMGC Grabs Precision Parts Maker Serving Boeing, Honeywell
Diversified holding company PMGC Holdings Inc. (NASDAQ:ELAB) shares rose in Wednesday premarket trading after a new acquisition announcement. PMGC acquired A&B Aerospace for $4.5 million, marking its fifth acquisition in the past 12 months. PMGC Expands Aerospace Manufacturing Platform PMGC acquired California-based A&B Aerospace, a precision-machining and aerospace manufacturing company serving the aerospace, defense, and industrial markets. A&B Aerospace was founded in 1948 and is headquartere
Wall Street Set to Open Higher as Trump Says US Will Consider Ceasefire if Hormuz Strait Opened
US stocks looked set to open higher in Wednesday's trading session after President Trump claimed tha